It was shown that the introduction of viral particles modified with muscle fusion proteins, either locally or systemically, could effectively transport micro‐dystrophin to the skeletal muscle of a mouse model of DMD, resulting in the alleviation of pathological symptoms. This evidence concerns the gene DMD and Duchenne muscular dystrophy.